Banner Advertiser

Sunday, April 10, 2011

[ALOCHONA] Bangladesh can earn more than $10 Billion from the pharmaceuticals sector



Amreteck Pharma USA believes that political calm, stability and low manpower cost could make Bangladesh a potential of Pharma outsourcing. M M Chowdhury, CEO of Amreteck Pharma USA has been interviewed by various well-known Pharma Outsource media and put a bright picture for Bangladesh (see below the links). However, Bangladesh Govt and Pharmaceuticals Industries will have to implement few recommendations that were communicated by CEO. The following Amreteck Pharma USA proposals need to be implemented immediately:

I. Developing Independent Drugs Testing Laboratories - Amreteck Pharma USA plans to propose current BD Govt to build an Independent Drugs Testing Laboratory with 50-50% joint-venture. This lab must be independent from the Bangladesh Pharmaceuticals companies to earn the trust from the export countries. This is one of the pillars that are needed to enhance export countries trust and bring down the cost of drugs potency & safety testing.

II. Pharmaceutical companies must develop Quality Management Systems and continue monitoring the systems. Amreteck Pharma has proposed various BD Pharma companies to build the Quality Management Systems and plan to work every step of the process to implement the Quality Management  System. Check www.amreteckpharma.com for more details.

III. BD Govt should provide 0% corporate tax for 5 years when foreign and local companies and or investors invest in the Pharmaceuticals sector. BD needs state of art pharmaceutical plants with right equipment and quality system to manufacture quality medicines. This can create 5 lack high paid jobs in the pharmaceuticals sector within 5 years.

IV. BD Govt should modify policy to expand oversees offices expense from US$2500 to US$1MM. Companies need this expanse cushion to expand their export market in the foreign countries.

V. BD Govt should provide incentives to small and medium pharmaceutical companies to be consolidated. There are more 250 small and medium sizes pharmaceutical companies and most of them does not have or can not afford to have quality Management system in place to manufacture quality medicines. They should be allowed to consolidate with providing bigger incentives. Amreteck Pharma USA can help companies with proposal and information during this consolidation and joint-venture process. Visit www.amreteckpharma.com for more info.

VI. BD Govt should bring foreign Consulting Companies to provide GMP (Good Manufacturing Practices) training and Audits techniques per USFDA. Amreteck Pharma has offered current BD Govt to train its Health Inspectors and is waiting for their response.

VII. BD Govt should implement curriculum in Colleges and Universities to add Pharmaceuticals Job training. Amreteck Pharma offers this training and BD Govt needs to come up with a plan how to implement Amreteck Pharma's proposal.

VIII. BD Govt needs to pay this down payment now to achieve $10 Billion dollar medicines export earning level in the next 10 years and this can create 5 lack high paid job within 5 years. There will be competition from India and China , but BD low cost manpower and low cost quality medicines will trump over them. Amreteck Pharma USA will formulate this plan if asked.

IX. This is not Garments industries, lots of investment and experts are needed to make this sector attractive and achievable. Amreteck Pharma USA also plans to provide Investment Seminars in various countries to bring NRB (Non-Resident Bangladeshi) investment in the BD pharmaceuticals sector. BD Govt should be teamed up with Amreteck Pharma USA to achieve this goal. See www.amreteckpharma.com for more details. Spread the news about the NBR investment opportunity in Bangladesh .

M M Chowdhury, CEO of Amreteck Pharma USA is supporting Bangladesh Pharmaceuticals Sector since 2007 and plays an important role to help this sector.  M M Chowdhury's working experience (six times) with US FDA will provide needed help to Bangladesh Pharmaceuticals companies to bring required GxP and regulatories compliance. Amreteck Pharma USA will open Branch Office at Dhaka on January 20, 2012.
 
Amreteck Pharma USA has three types of businesses as below:
1. Pharmaceuticals Consulting Group
2. Medical Devices Distribution Group
3. Laboratories & Clinical Trials Services Group 
 
Please visit us at www.amreteckpharma.com (The website is under updates/construction)

CEO of Amreteck Pharma interviewed by various newspapers in Europe and Bangladesh about Pharma-outsourcing. See below few of them:

1) Shortcut to: http://www.outsourcing-pharma.com/On-your-radar/Globalisation/Bangladesh-a-huge-opportunity-for-growth-CEO
 
Regards,
Mr. M. M. Chowdhury, ChE, Engineering, Validation, Quality & GMP Expert
Founder/CEO/Pharmaceuticals Consultant, Amreteck®  Pharma USA
 
               
Phone:   (678) 858-5952 - Office
              (307) 213-9878 - Office
              (307) 586-1840 - Office
Fax:       (541) 753-1626 - Office
 
 
 
Amreteck Sponsors of "Pharma in Bangladesh":



__._,_.___


[Disclaimer: ALOCHONA Management is not liable for information contained in this message. The author takes full responsibility.]
To unsubscribe/subscribe, send request to alochona-owner@egroups.com




Your email settings: Individual Email|Traditional
Change settings via the Web (Yahoo! ID required)
Change settings via email: Switch delivery to Daily Digest | Switch to Fully Featured
Visit Your Group | Yahoo! Groups Terms of Use | Unsubscribe

__,_._,___